International Suicide Prevention Trial InterSePT Study Design Efficacy and Safety Results

Rocco Zaninelli, MD

Executive Director

Clinical Research and Development

Novartis Pharmaceuticals Corporation

C

Next slide

Back to first slide

View graphic version